Nehu

Login

Healthcare

Navigating the Intersection of AI and Biology: A Vision for Drug Discovery| Sean McClain, CEO, Absci Corp.

Revolutionizing Drug Discovery with AI: Accelerating Medicine Development through Innovative Biologics| Sean McClain, CEO, Absci Corp.

Exploring Breakthroughs: Insights into Mitochondrial Disease Treatments and Clinical Trials | Ellen Wittmack Donnelly, CEO, Abliva AB.

Navigating Biotech Leadership: Insights, Risks, and Personal Growth from an Industry Veteran | Marc de Garidel, CEO, Abivax SA.

Phase 2a Trial of CER-001 for Septic Patients and Future Biotech Meetings | Cyrille Tupin, CEO, Abionyx Pharma SA .

From Tinkering with Appliances to Transforming Clinical Trials|Ryan Jones,CEO,Florence Healthcare

CEO Alain Moussy Expounds on the Complex Journey of Masitinib Development in Interview| Alain Moussy, CEO, AB Science SA.

Navigating the Challenging Landscape of NASH Therapeutics| Rohan Palekar, CEO, 89bio Inc.

4D Medical Achieves Milestone: Generates First Clinical SAS Revenue and Explores International Expansion with Revolutionary Respiratory Imaging Technology| Dr Andreas Fouras, CEO, 4dmedical ltd.

Transforming Respiratory Diagnostics: 4D Medical's Innovative Healthcare Journey| Dr Andreas Fouras, CEO, 4dmedical ltd.

Revolutionizing Genetic Research Through Consumer Empowerment and Participation|Anne Wojcicki, CEO, 23andme holding co.

Revolutionizing Healthcare Through Genetic Transparency and Choice|Anne Wojcicki, CEO, 23andme holding co.

Grindeks chairman of the board Juris Hmelnickis

Dr. Dan Bloomfield Discusses Abelacimab's Advantages | JOHN GLASSPOOL, CEO, ANTHOS THERAPEUTICS

Apollo Therapeutics: Converting cutting-edge research into possible treatments | Dr Richard Mason, CHIEF EXECUTIVE OFFICER, APOLLO THERAPEUTIC

Applied Pharmaceuticals and Voyageur Pharmaceuticals collaborate on carbon-based imaging medications | Andrew MacIsaac, CHIEF EXECUTIVE OFFICER, APPLIED PHARMACEUTICAL INNOVATION

«
1
2
...
25
26
27
28
29
30
31
...
69
70
»